here Anxienty is closely related to sexual disorders, being their source, preserver, and consequence.Therefore, it represents an important obstacle in the course of a therapy.The role of anxiety in sexual disorders has already been widely investigated, but the question whether the above mentioned connection exists at a micro level remains unanswere
Characterization of a human cell line stably over-expressing the candidate oncogene, dual specificity phosphatase 12.
Analysis of chromosomal rearrangements within primary tumors has been influential in the identification of novel oncogenes.Identification of the "driver" gene(s) within cancer-derived amplicons is, however, hampered by the fact that most amplicons contain many gene products.Amplification of 1q21-1q23 is strongly associated with liposarcomas and mic
Doubly Optimal Parallel Wire Cutting without Ancilla Qubits
A restriction in the quality and quantity of available qubits presents a substantial obstacle to the application of near-term and early fault-tolerant quantum computers in practical tasks.To confront this challenge, some techniques for effectively augmenting the system size through classical processing have been proposed; one promising approach is
A hepatitis C-positive patient with new onset of nephrotic syndrome and systemic amyloidosis secondary to common variable immunodeficiency
Common variable immunodeficiency (CVID) is a heterogenous group of predominantly antibody-deficiency disorders that make up the greatest proportion of patients with symptomatic primary hypogammaglobulinemia.The rare coincidence of amyloidosis and hypogammaglobulinemia has been reported previously.Contrary to the usual insidious, slowly progressive
Combining AdipoRon with Paclitaxel Unveils Synergistic Potential in Non-Small Cell Lung Cancer Cells via AMPK-ERK1/2 Signaling
As part of chemotherapy regimens, Paclitaxel improves the overall survival of many non-small cell lung cancer (NSCLC) patients.However, the development of drug resistance and adverse events limits its clinical usage, reinforcing the need for further advancements in NSCLC therapeutics.We recently recognized the adiponectin receptor agonist AdipoRon